Gynae BT 2017

Comparison 1 NACT followed by RT vs RT

 18 trials

 N = 2074

 92% of patients from all eligible trials

 Survival data available from all trials

 Median FU – 5.7 years

 70% pts had stage II or III disease

 Lymph node status unknown in 60%

GUSTAVE ROUSSY

THÈME DU DIAPORAMA